Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,489 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer.
Abraham JE, Pinilla K, Dayimu A, Grybowicz L, Demiris N, Harvey C, Drewett LM, Lucey R, Fulton A, Roberts AN, Worley JR, Chhabra A, Qian W, Vallier AL, Hardy RM, Chan S, Hickish T, Tripathi D, Venkitaraman R, Persic M, Aslam S, Glassman D, Raj S, Borley A, Braybrooke JP, Sutherland S, Staples E, Scott LC, Davies M, Palmer CA, Moody M, Churn MJ, Newby JC, Mukesh MB, Chakrabarti A, Roylance RR, Schouten PC, Levitt NC, McAdam K, Armstrong AC, Copson ER, McMurtry E, Tischkowitz M, Provenzano E, Earl HM. Abraham JE, et al. Among authors: chakrabarti a. Nature. 2024 May;629(8014):1142-1148. doi: 10.1038/s41586-024-07384-2. Epub 2024 Apr 8. Nature. 2024. PMID: 38588696 Free PMC article. Clinical Trial.
Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): an open-label, randomised, phase 3 trial.
Earl HM, Hiller L, Dunn JA, Blenkinsop C, Grybowicz L, Vallier AL, Abraham J, Thomas J, Provenzano E, Hughes-Davies L, Gounaris I, McAdam K, Chan S, Ahmad R, Hickish T, Houston S, Rea D, Bartlett J, Caldas C, Cameron DA, Hayward L; ARTemis Investigators. Earl HM, et al. Lancet Oncol. 2015 Jun;16(6):656-66. doi: 10.1016/S1470-2045(15)70137-3. Epub 2015 May 11. Lancet Oncol. 2015. PMID: 25975632 Free article. Clinical Trial.
Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial.
Velikova G, Williams LJ, Willis S, Dixon JM, Loncaster J, Hatton M, Clarke J, Kunkler IH, Russell NS; MRC SUPREMO trial UK investigators. Velikova G, et al. Lancet Oncol. 2018 Nov;19(11):1516-1529. doi: 10.1016/S1470-2045(18)30515-1. Epub 2018 Oct 15. Lancet Oncol. 2018. PMID: 30337220 Free article. Clinical Trial.
Tumour shrinkage and contour change during radiotherapy increase the dose to organs at risk but not the target volumes for head and neck cancer patients treated on the TomoTherapy HiArt™ system.
Loo H, Fairfoul J, Chakrabarti A, Dean JC, Benson RJ, Jefferies SJ, Burnet NG. Loo H, et al. Among authors: chakrabarti a. Clin Oncol (R Coll Radiol). 2011 Feb;23(1):40-7. doi: 10.1016/j.clon.2010.09.003. Epub 2010 Oct 6. Clin Oncol (R Coll Radiol). 2011. PMID: 20926268
Management of adult sepsis in resource-limited settings: global expert consensus statements using a Delphi method.
Thwaites L, Nasa P, Abbenbroek B, Dat VQ, Finfer S, Kwizera A, Ling L, Lobo SM, Sinto R, Aditianingsih D, Antonelli M, Arabi YM, Argent A, Azevedo L, Bennett E, Chakrabarti A, De Asis K, De Waele J, Divatia JV, Estenssoro E, Evans L, Faiz A, Hammond NE, Hashmi M, Herridge MS, Jacob ST, Jatsho J, Javeri Y, Khalid K, Chen LK, Levy M, Lundeg G, Machado FR, Mehta Y, Mer M, Son DN, Ospina-Tascón GA, Ostermann M, Permpikul C, Prescott HC, Reinhart K, Rodriguez Vega G, S-Kabara H, Shrestha GS, Waweru-Siika W, Tan TL, Todi S, Tripathy S, Venkatesh B, Vincent JL, Myatra SN. Thwaites L, et al. Among authors: chakrabarti a. Intensive Care Med. 2024 Dec 23. doi: 10.1007/s00134-024-07735-7. Online ahead of print. Intensive Care Med. 2024. PMID: 39714613 Review.
1,489 results